Pharmaceutical Technology
JULY 15, 2022
The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. The documents state that a partnership with a CMO would be cheaper than the state directly manufacturing insulin. Prices would be “a fraction of the $300 per vial prices charged by insulin manufacturers.”.
The Pharma Data
JULY 22, 2021
Sanofi has concluded an agreement to divest an integrated portfolio of dental care brands and related medical devices to Septodont, a French privately-owned company headquartered near Paris. The group counts 1,900 employees and has a long-established presence in more than 150 countries. Source link: [link].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 30, 2023
The biotech transferred the rights for alendronate to Merck which marketed the drug under the brand name Vancapsi. Separate from drug development, the Italian company also offers contract manufacturing and clinical supply services.
Pharmaceutical Technology
FEBRUARY 24, 2023
The company also offers contract manufacturing and laboratory services. It markets its consumer products under various brands which include 3M Futuro, Altrix Range, Avene, Bio Oil, Puria and Resolve, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.
Pharmaceutical Technology
FEBRUARY 24, 2023
The company also offers contract manufacturing and laboratory services. It markets its consumer products under various brands which include 3M Futuro, Altrix Range, Avene, Bio Oil, Puria and Resolve, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.
Camargo
JANUARY 19, 2021
They also have multiple clients, and thus by definition have many demands on their time and resources, particularly their manufacturing equipment and analytical capabilities. Brand Name. While the FDA will accept and even approve an NDA without one, the Agency must approve the brand name before it can be used to promote the product.
pharmaphorum
AUGUST 10, 2020
Gilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the brand name Veklury. Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.
Expert insights. Personalized for you.
328 
Let's personalize your content